Next Financial Group’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$0 Sell
1
-1
-50% -$236 ﹤0.01% 2867
2021
Q3
$0 Hold
2
﹤0.01% 2745
2021
Q2
$1K Hold
2
﹤0.01% 2494
2021
Q1
$1K Hold
2
﹤0.01% 2380
2020
Q4
$1K Hold
2
﹤0.01% 2252
2020
Q3
$1K Buy
+2
New +$1.56K ﹤0.01% 2088
2020
Q2
Sell
-1
Closed -$1K 753
2020
Q1
$1K Hold
1
﹤0.01% 1988
2019
Q4
$1K Hold
1
﹤0.01% 2255
2019
Q3
$1K Hold
1
﹤0.01% 2198
2019
Q2
$2K Buy
+1
New +$1.73K ﹤0.01% 2096
2019
Q1
Sell
-1
Closed -$2K 1666
2018
Q4
$2K Buy
+1
New +$1.53K ﹤0.01% 1723
2017
Q4
Sell
-1
Closed -$2K 383
2017
Q3
$2K Buy
+1
New +$1.4K ﹤0.01% 1587
2017
Q1
Sell
-24
Closed -$19K 1907
2016
Q4
$19K Buy
24
+7
+41% +$5.56K ﹤0.01% 1379
2016
Q3
$15K Buy
+17
New +$12.3K ﹤0.01% 1473
2016
Q1
Sell
-5
Closed -$3K 1729
2015
Q4
$3K Buy
5
+1
+25% +$999 ﹤0.01% 1503
2015
Q3
$4K Sell
4
-16
-80% -$29.2K ﹤0.01% 1466
2015
Q2
$42K Buy
20
+5
+33% +$10.2K 0.01% 730
2015
Q1
$24K Hold
15
0.01% 917
2014
Q4
$18K Hold
15
0.01% 1012
2014
Q3
$7K Hold
15
﹤0.01% 1913
2014
Q2
$7K Buy
+15
New +$4.81K ﹤0.01% 841

Other funds holding BLUE

Next Financial Group's BLUE Position: Q4 2021 in Review

Next Financial Group reduced its bluebird bio (BLUE) stake by 50% in Q4 2021, selling an estimated $236 and leaving 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2867.

Next Financial Group first reported a position in BLUE in Q2 2014 and has held it in 21 quarters since. The position peaked at $42K in Q2 2015. 172 funds tracked by Wall St. Rank hold BLUE as of Q4 2021.

  • Next Financial Group held 1 share of bluebird bio worth $0 as of Q4 2021.
  • Next Financial Group sold 1 bluebird bio share in Q4 2021, an estimated $236.
  • bluebird bio made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2867 holding.
  • Next Financial Group first reported a position in bluebird bio in Q2 2014 and has held it in 21 quarters since.
  • Next Financial Group's bluebird bio position peaked at $42K in Q2 2015.
  • 172 funds tracked by Wall St. Rank held bluebird bio as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.